Cargando…
Plasma Fibroblast Growth Factor 23 Concentration Is Increased and Predicts Mortality in Patients on the Liver-Transplant Waiting List
High plasma fibroblast growth factor-23 (FGF23) concentration predicts the risk of death and poor outcomes in patients with chronic kidney disease or chronic heart failure. We checked if FGF23 concentration could be modified in patients with end stage liver disease (ESLD) and predict mortality. We m...
Autores principales: | Prié, Dominique, Forand, Anne, Francoz, Claire, Elie, Caroline, Cohen, Isabelle, Courbebaisse, Marie, Eladari, Dominique, Lebrec, Didier, Durand, François, Friedlander, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692511/ https://www.ncbi.nlm.nih.gov/pubmed/23825530 http://dx.doi.org/10.1371/journal.pone.0066182 |
Ejemplares similares
-
Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study
por: Arlet, Jean-Benoît, et al.
Publicado: (2012) -
The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method
por: Bienaimé, Frank, et al.
Publicado: (2017) -
A New Human NHERF1 Mutation Decreases Renal Phosphate Transporter NPT2a Expression by a PTH-Independent Mechanism
por: Courbebaisse, Marie, et al.
Publicado: (2012) -
Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease
por: Michon-Colin, Arthur, et al.
Publicado: (2023) -
The Phosphate Transporter PiT1 (Slc20a1) Revealed As a New Essential Gene for Mouse Liver Development
por: Beck, Laurent, et al.
Publicado: (2010)